Overview
* Scotts Miracle-Gro ( SMG ) Q4 revenue missed analyst expectations
* Adjusted EBITDA for Q4 beats estimates
Outlook
* Scotts Miracle-Gro ( SMG ) expects U.S. Consumer net sales low single-digit growth in fiscal 2026
* Company projects non-GAAP adjusted EPS of $4.15 to $4.35 for fiscal 2026
* Scotts Miracle-Gro ( SMG ) anticipates free cash flow of $275 mln, reducing leverage ratio to high 3's
Result Drivers
* GROSS MARGIN IMPROVEMENT - Co achieved significant gross margin improvement, increasing by 670 basis points over prior year
* COST SAVINGS - Strategic implementation of AI and robotic automation contributed to cost savings, allowing reinvestment in brands and channel expansion
* U.S. CONSUMER SALES - U.S. Consumer net sales of $2.99 bln were in line with guidance, showing resilience in the consumer segment
Key Details
Metric Beat/Mis Actual Consensu
s s
Estimate
Q4 Sales Miss $387.40 $397.30
mln mln (9
Analysts
)
Q4 Beat -$1.96 -$1.99
Adjusted (8
EPS Analysts
)
Q4 EPS -$2.63
Q4 Net -$151.80
Income mln
Q4 Beat -$81.60 -$86 mln
Adjusted mln (7
EBITDA Analysts
)
Q4 Gross 23.50%
Margin
Q4 Basic -$2.63
EPS
Q4 -$150.10
Operatin mln
g Income
Q4 -$190.60
Pretax mln
Profit
Analyst Coverage
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
* The average consensus recommendation for the agricultural chemicals peer group is "buy"
* Wall Street's median 12-month price target for Scotts Miracle-Gro Co ( SMG ) is $70.50, about 22.8% above its November 4 closing price of $54.46
* The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 15 three months ago
Press Release:
For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)